HCID 59442734, compound → 3-Amino-N-methyl-5-(trifluoromethyl)benzamide
Reaction equation
[F:1][C:2]([F:17])([F:16])[C:3]1[CH:8]=[C:7]([N+:9]([O-])=O)[CH:6]=[C:5]([C:12]([NH:14][CH3:15])=[O:13])[CH:4]=1.N1(C2C=C(C=C([N+]([O-])=O)C=2)C(NC)=O)CCOCC1>>[NH2:9][C:7]1[CH:6]=[C:5]([CH:4]=[C:3]([C:2]([F:1])([F:16])[F:17])[CH:8]=1)[C:12]([NH:14][CH3:15])=[O:13]Participants
3
Procedure
Utilising the procedure described in Example 86e, but employing α,α,α-trifluoro-N-methyl-5-nitro-m-toluamide (Dean E. Welch, J. Med. Chem. (1969),12, 299–303) in lieu of 3-(4-morpholinyl)-5-nitro-N-(methyl)-benzamide, afforded the title compound as a beige crystalline solid, m.p. 113–115° C.
Sources & evidence
- ORD record
- ord-0016656ef7e348cdb35ee376bf8f9d2f
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07169791B2
Reaction notes
Loading…